Aptevo Therapeutics Inc.

Q2 2024 13F Holders

Symbol
APVO
CUSIP
03835L306
Type
Equity
Class
COM
Num filers
19
Total reported value, excl. options
$599 k
Manager Report Date Value ($000) Shares Option Type